Hans Messner Allogeneic BMT Program

Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.

[Hans Messner Allogeneic BMT Program @Hans_BMTProgram]

Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

📢 Now out in @BrJHaem 🎊🎉

Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up)
https://t.co/wCsdX5WDzf

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

📢 Published in @ASTCT_Journal 🎉

Using a large dataset (@CIBMTR + @Hans_BMTProgram), we show that ATG + PTCy may alleviate the ⤴️GvHD risk associated with female donor-to-male recipient MUD transplants 🙌🏽
https://t.co/p9epD40RbD

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

🎉 Out now in @ASTCT_Journal 🙌🏽

We compare two conditioning regimens for second allogeneic transplant after primary graft failure!

Interesting results 👇🏽
DM me for the PDF!

https://t.co/5ESeV8lPwl @Hans_BMTProgram

[Ahmed AlNughmush @AhmedAlNughmush]

Our work is now out in @ASTCT_Journal

We looked into the association between cumulative cyclosporine exposure over the first 90 days (AUC90) post-HCT and key transplant outcomes, including graft failure and relapse.

@Hans_BMTProgram

https://t.co/hWEHnFM6fV

[Ruah Alyamany | روى اليماني @Ruah_Mahmoud]

Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual T-cell depletion for GVHD prophylaxis.
#Hematology #BMT

@AhmedAlNughmush @Hans_BMTProgram

https://t.co/ht6lNaMkmx

[Arjun D. Law @Haemophage]

Proud moment at the CTTC Conference!
Here’s a roundup of phenomenal poster presentations from our team at @Hans_BMTProgram @UHN and @pmcancercentre , tackling real-world challenges in transplant medicine and GVHD.
#CTTC2025 #HCT #GVHD #HemeTwitter
1/10

[Sergio Rodríguez-Rodriguez, MD, MSc. 🇲🇽 @SergioRdzRdz]

🚨 New Study Alert!
@nihardesai89 @Haemophage @IvanPasic

Our team retrospectively analyzed our cohort on allogeneic HSCT outcomes in patients with MDS/MPN overlap syndromes—a rare and challenging group of hematologic neoplasms. 🧵👇

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

Excellent thread summarising key findings of our latest publication from @pmcancercentre 👇🏽

DM me if you want the PDF 🙌🏽

https://t.co/ryfscQagL2 #MedTwitter @SergioRdzRdz @Hans_BMTProgram @Haemophage

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

The abstract titles for #ASCO25 are out 🙌🏽

We asked 2 questions:
1. Can we ⤵️the PTCy dose in MUDs?

2. What's the outcome of patients who are alive 2 yr post transplant?

We'll answer those questions at the oral abstract session @ASCO

#MedTwitter @Hans_BMTProgram

[Hans Messner Allogeneic BMT Program @Hans_BMTProgram]

@pmcancercentre Thank you so much for your kind words! 💙
It is truly our privilege to be part of your journey and we’re grateful for the trust you placed in our team. Wishing you continued health and wellness!

[Princess Margaret Cancer Centre @pmcancercentre]

Exciting news from a dear patient. Thank you for sharing your journey with us.

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

🎉🎉🎉Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago!

As always, I'm thankful to @Haemophage and the team at @pmcancercentre for the phenomenal mentorship 🙌🏽

Looking forward to a great discussion and meeting some solid oncologists 🤣

#MedTwitter

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

🎉🎉 200 ALLOGENEIC transplants in a year is no mean feat 💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽

I am proud to be a part of this amazing team 💪🏽

P.S. We are on track for 250 this year 🙌🏽

#MedTwitter @Haemophage @Hans_BMTProgram @PanktiMehta24 @SergioRdzRdz @NicoGagelmann

[Hans Messner Allogeneic BMT Program @Hans_BMTProgram]

Huge milestone!
Today our centre infused the 200th AlloBMT for this fiscal year. That’s 200 Allogeneic Stem Cell Transplants THIS YEAR (overall we’re >5k) and we’re still going strong! A new record!
#AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF

[Arjun D. Law @Haemophage]

Wow! What a phenomenal team we work with at @Hans_BMTProgram !
It truly takes a village to achieve such a monumental goal.

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

I am pleased to present 3 posters and chair a session at @TheEBMT annual meeting in Florence 🙌🏽

Can't wait to meet the mad lot we call @TheEBMT_Trainee 🤣🤣

@Hans_BMTProgram #MedTwitter